Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms

NCT07272512

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • Huadong Hospital Affiliated to Fudan University Shanghai, China
  • Huashan Hospital Affiliated to Fudan University Shanghai, China
  • Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine Shanghai, China
  • Shanghai General Hospital shanghai jiao tong university school of medicine Shanghai, China
View Trial Details
Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

NCT06943521

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Cancer, +75 more
Locations
  • University of Southern California Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations
  • Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
  • Massive Bio SYNERGY-AI site Mobile, Alabama, United States
  • Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
  • Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Recruiting

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

NCT06805825

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Albinism, +58 more
Locations
  • University of Michigan Hospitals Ann Arbor, Michigan, United States
  • Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions